Average Co-Inventor Count = 6.05
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Immatics Biotechnologies Gmbh (347 from 725 patents)
2. Other (1 from 831,952 patents)
3. Morphosys Ag (1 from 88 patents)
348 patents:
1. 12351616 - Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
2. 12297254 - Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
3. 12295996 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
4. 12295995 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
5. 12295994 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
6. 12275775 - Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
7. 12275776 - Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
8. 12258382 - Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
9. 12234276 - Uterine cancer treatments
10. 12226466 - Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
11. 12226467 - Peptides and combination of peptides for use in immunotherapy against various cancers
12. 12221626 - Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
13. 12221468 - Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
14. 12221467 - Uterine cancer treatments
15. 12214025 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers